Kriya Therapeutics Stock

kriyatherapeutics.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $617.63MM

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy.

Register for Details

For more details on financing and valuation for Kriya Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Kriya Therapeutics.

Register Today

Kriya Therapeutics investors also invested in these private companies

Team

Management Team

Shankar Ramaswamy, MD
Co-Founder & Chief Executive Officer
Nachi Gupta, MD, PhD
President, Technology
Melissa Rhodes, PhD, DABT
President, Research and Development
Neera Ravindran, MD
Chief Financial Officer
Ilise Lombardo, MD
President
Michele Stone, PhD
Chief Scientific Officer

Board Members

Jim Momtazee
Patient Square Capital
CR Sincock II
Transhuman Capital
Saira Ramasastry
Life Sciences Advisory
Roger Jeffs, PhD
Kriya Therapeutics
Neel Varshney, MD
Patient Square Capital
Keith Manchester, MD
Life Sciences for QVT Family Office

Other companies like Kriya Therapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B